Chymotra at Spray


Product Info

Prescription required Yes
Marketer Adroit Lifescience Pvt Ltd
Active Ingredient Minoxidil (5% w/v)
Storage Store below 30°C
Chemical ClassDialkylarylamines
Habit FormingNo
Therapeutic ClassDERMA
Action ClassPotassium channel opener
User Rating4.7
User Reviews343

FAQ

Question
Is the hair growth by Chymotra at treatment permanent?
You have to continue applying Chymotra at for continued hair growth. If you stop using Chymotra at, the regrown hair may disappear after 3-4 months and balding or hair loss may restart.
Answer

Question
Do I need to wash my hair every day when using Chymotra at?
No, it is not required to shampoo your hair every day before applying Chymotra at. However, if you shampoo your hair, make sure your scalp is dry before using Chymotra at.
Answer

Question
Can Chymotra at be used for beard growth?
No, Chymotra at should not be used for beard growth. It is indicated only for growth of hair on scalp in patients with a family history of hair loss.
Answer

Question
How long does it take to see results with Chymotra at?
Since hair growth is a slow process, it may take some time before you see new hair growth after starting the treatment with Chymotra at. You need to use Chymotra at for 4 months to see its effects.
Answer

Question
How often should Chymotra at be applied?
The general recommendation is that Chymotra at should be used twice daily. Follow your doctor's instructions and take it in the dose and duration advised by your doctor.
Answer
Question
What if you forget to take Chymotra Solution?
If you miss a dose of Chymotra at, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Answer

Chymotra at Spray Reviews

Chymotra at belongs to a class of drugs known as vasodilators. It is used to promote hair growth in men with male pattern baldness.

Chymotra at should only be applied directly to the scalp area in the amount and in the way specified on the label or by your doctor. Clean and dry your scalp before using it. It may take approximately 2- 4 months before you notice any hair growth. The first growth may be soft, colourless, and barely visible. Using more than recommended will not speed up hair growth and may increase the likelihood of side effects. This medication must be used continuously to maintain hair growth. Tell your doctor if your condition does not improve or worsen after using it for 4 to 6 months.

The most common side effects of this medicine include itching, excessive hair growth, rash, and dermatitis. In case of accidental application in other areas, it may result in unwanted hair growth. Rinse thoroughly with plenty of water if you get it in your eyes, mouth, or broken skin. Talk to your doctor if you are bothered by the side effects or if they do not go away.

People under 18 or over 65 should not usually use Chymotra at. It may also not be appropriate if your hair loss is due to medications (such as chemotherapy) or any nutritional deficiency. You should also not use this medicine if you have high blood pressure or use other creams or lotions to treat other scalp conditions. Talk to your doctor if you have heart disease or blood circulation problems.

How Chymotra at Spray Works

Chymotra at is a potassium channel opener. Its vasodilation action expands the blood vessels. Therefore, when it is applied to the scalp, it helps to increase blood flow. This increased blood flow provides more nutrition and oxygen to the hair follicles, which prevents hair cell death and also enhances new hair growth. This is how it works to treat your alopecia (hair loss).

How to Use Chymotra at Spray

Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.

Benefits of Chymotra at Spray

  • In Treatment of Hair loss: Chymotra at is a medicine used to treat common hereditary hair loss. It can prevent further hair loss and help hair to re-grow. It works by increasing blood flow to the hair follicles on your scalp, which prevents hair cell death and also enhances new hair growth. It is most effective for baldness or thinning at the top of the scalp but less effective at the front or for receding hairline. Benefits are less likely if you have been bald for many years or have a large area of hair loss. Chymotra at is not suitable for sudden or unexplained hair loss. It is considered a safe medicine. There are separate products for men and women and you should follow your doctor’s instructions carefully while using Chymotra at. Regrowth of hair improves your appearance, boosts your confidence, and enhances your social life. Use it regularly to maintain hair growth and to get the maximum benefits. Consult your doctor if you notice any changes in the hair growth while using Chymotra at.

Uses of Chymotra at Spray

  • Treatment of Hair loss

Chymotra at Spray Side Effects

Item form

Safety Tips

Pregnancy  CONSULT YOUR DOCTOR
Chymotra at may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding  CONSULT YOUR DOCTOR
Chymotra at is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Chymotra at is not recommended for use in women.

Quick Tips

  • During the first 2 weeks of application, your hair fall may increase. This is normal and is a sign that Chymotra at is working.
  • Take care that Chymotra at does not trickle down onto your face as it may cause undesirable facial hair growth.
  • It should only be applied directly to the scalp. If Chymotra at accidentally comes in contact with your eyes, nose, or mouth, flush the area thoroughly with cool tap water.
  • Wash your hands before and after application.
  • Do not shampoo your hair or use a hairdryer for 4 hours after applying Chymotra at as it can reduce the effectiveness of the medicine.

References

  1. Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1829.
  2. Minoxidil. Maidenhead, Berks: McNeil Products Ltd.; 2010 [revised 01 May 2018].
  3. Central Drugs Standard Control Organisation (CDSCO).
  4. Benowitz NL. Antihypertensive Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 179.
  5. 2% Minoxidil Topical Solution [Product Label]. Skillman, NJ: Johnson & Johnson Healthcare Products; 2014.
  6. Minoxidil. Val-de-Reuil, France: Janssen-Cilag; 2018.
  7. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 922-24.
  8. Minoxidil 5% cutaneous solution [Package leaflet: Information for the user]. London, UK: Careforsons Limited; 2020.
  9. Minoxidil (For Women) [FDA Label]. Jersey City, NJ: International Hair Institute, LLC; 2022.
  10. Minoxidil (5% w/v cutaneous solution) [Package Information Leaflet]. Athens, Greece: Target Pharma Ltd.; 2012.
  11. Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198.
  12. Minoxidil (For Men) [FDA Label]. Hawthorne, NY: Taro Pharmaceuticals U.S.A., Inc.; 2021.
  13. 5% Minoxidil Topical Solution [Product Information]. New York, NY: Avacor Products LLC; 2019.

Other Medical Preparations